Showing 1-10 of 14 results for "".

• Alexis Buffington, BS
  https://practicaldermatology.com/profiles/alexis-buffington-bs/Lom41V/

• Andrew F. Alexis, MD, MPH

  https://practicaldermatology.com/topics/general-topics/andrew-f-alexis-md-mph/21369/
  • Text

• Can UV Nail Dryers Cause Skin Cancer?

  https://practicaldermatology.com/topics/hair-nails/can-uv-nail-dryers-cause-skin-cancer/23898/
  Alexis Livingston Young, MD, weighs in on the evidence.
  • Text

• Dispatches from the 2022 Skin of Color Update

  https://practicaldermatology.com/conferences/skin-of-color-update-2022/dispatches-from-the-2022-skin-of-color-update/23822/
  Co-chair Dr. Andrew F. Alexis shares highlights from the recent meeting.
  • Text

• Photoprotection in Diverse Patient Populations

  https://practicaldermatology.com/programs/practical-dermatology/photoprotection-in-diverse-patient-populations/18196/
  In part one of a three-part podcast series on dermatologic issues facing patients with darker skin tones, Drs. Andrew Alexis, Corey Hartman, and Janiene Luke discuss photoprotection and why it matters for all patients. 
  • Audio
  • Podcast

• Laser hair removal in darker skin types, challenges and technological advances for treatment

  https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/laser-hair-removal-in-darker-skin-types-challenges-and-technological-advances-for-treatment/18800/
  Andrew Alexis, MD discusses laser hair removal treatment challenges in patients with higher Fitzpatrick skin types, and how recent advances in technology have been able to address these to deliver effective treatment with minimal pain.
  • Video

• FDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)

  https://practicaldermatology.com/series/dermwire-tv/fda-approves-eli-lillys-ad-drug-ebglyss-lebrikizumab/28645/
  In this week's DermwireTV, Andrew F. Alexis, MD, Professor of Clinical Dermatology at Weill Cornell Medical College, discusses the newly approved AD drug lebrikizumab; LEO Pharma announces two major regulatory milestones for its chronic hand eczema (CHE) treatment; and the CMO of Arcutis Bioteherapu
  • Video

• The Use of Lasers and Energy-Based Devices in Patients with Richly Pigmented Skin

  https://practicaldermatology.com/programs/practical-dermatology/the-use-of-lasers-and-energy-based-devices-in-patients-with-richly-pigmented-skin/18199/
  In the last of a three-part podcast series on dermatologic issues facing patients with darker skin tones, Andrew Alexis, MD, a dermatologist from New York City and the President of the Skin of Color Society, Corey Hartman, MD, a dermatologist in Birmingham, Alabama, and Janiene Luke, MD, a dermatolo
  • Audio
  • Podcast

• Time Is Hair: An Update on the Diagnosis and Treatment of Scarring Alopecias in Patients with Darker Skin Tones

  https://practicaldermatology.com/programs/practical-dermatology/time-is-hair-an-update-on-the-diagnosis-and-treatment-of-scarring-alopecia-in-patients-with-darker-skin-tones/18198/
  In part two of a three-part podcast series on dermatologic issues facing patients with darker skin tones, Dr. Andrew Alexis, a dermatologist from New York City and the President of the Skin of Color Society; Dr. Corey Hartman, a dermatologist in Birmingham, Alabama; and Dr. Janiene Luke, a dermatolo
  • Audio
  • Podcast

• DermWireTV 09.12.19: Otezla to Amgen, A Juvéderm First, Skin Cancer Foundation News

  https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-091219-otezla-to-amgen-a-juvederm-first-skin-cancer-foundation-news/19663/
  After traveling more than 10,000 miles across the US, the Skin Cancer Foundation’s “Destination: Healthy Skin” Program is wrapping up for the season. Plus, the Champions for Change Gala is coming October 17. Amgen has entered into an agreement with Celgene Corporation Company to acquire worldwide ri
  • Video

• Prev
• 1
• 2
• Next